• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylcarbamic acid esters

Carbamic acid,(4-methyl-1,3-phenylene)bis-, bis(1-methylethyl) ester (9CI) and CAS No. 42592-07-4: A Comprehensive Overview

Carbamic acid,(4-methyl-1,3-phenylene)bis-, bis(1-methylethyl) ester (9CI), identified by the CAS number 42592-07-4, is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, with its unique structural and chemical properties, presents a promising avenue for exploring novel therapeutic applications. The name of the compound itself provides valuable insights into its molecular structure, which is characterized by a phenylene backbone substituted with methyl and ethyl groups, further modified by carbamic acid esters.

The significance of this compound in modern chemistry cannot be overstated. Its molecular framework, featuring a rigid aromatic system interconnected by ester functionalities, makes it an intriguing candidate for various biochemical interactions. Recent studies have highlighted the potential of such derivatives in modulating enzyme activity and interacting with biological targets. The presence of multiple stereocenters and the ability to undergo selective modifications make this compound a versatile scaffold for drug design.

In the realm of pharmaceutical innovation, the application of Carbamic acid,(4-methyl-1,3-phenylene)bis-, bis(1-methylethyl) ester (9CI) extends beyond mere structural curiosity. Researchers are increasingly leveraging its chemical properties to develop new analogs with enhanced pharmacological profiles. For instance, modifications to the ester groups can alter solubility and metabolic stability, critical factors in drug formulation. Additionally, the phenylene core offers opportunities for π-stacking interactions with biological molecules, which could be exploited in designing more effective binding agents.

The synthesis of this compound involves intricate organic transformations that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to achieve high yields and purity levels, ensuring that researchers can conduct detailed mechanistic studies without interference from impurities. Techniques such as palladium-catalyzed cross-coupling reactions and directed ortho-metalation have been particularly useful in constructing the desired molecular architecture.

One of the most compelling aspects of Carbamic acid,(4-methyl-1,3-phenylene)bis-, bis(1-methylethyl) ester (9CI) is its potential in medicinal chemistry. The compound's ability to engage with biological systems suggests it could serve as a lead molecule for developing treatments against various diseases. Preliminary computational studies have indicated that it may exhibit inhibitory activity against certain enzymes implicated in inflammatory responses. This aligns with the growing interest in targeting inflammation as a therapeutic strategy for chronic conditions.

The role of computational chemistry in understanding the behavior of this compound cannot be overlooked. Molecular modeling techniques have been instrumental in predicting how it interacts with proteins and other biomolecules. These simulations provide valuable insights into binding affinities and potential side effects, allowing researchers to optimize its pharmacological properties before moving to in vivo testing. Such advancements underscore the importance of interdisciplinary approaches in modern drug discovery.

Evaluation of the compound's physicochemical properties is essential for determining its suitability for various applications. Parameters such as melting point, solubility, and thermal stability provide critical information for formulating drugs that can withstand storage and transportation conditions. Additionally, spectroscopic methods like NMR and mass spectrometry have been employed to confirm its molecular structure and purity.

The environmental impact of synthesizing and using Carbamic acid,(4-methyl-1,3-phenylene)bis-, bis(1-methylethyl) ester (9CI) is another area of consideration. Efforts are being made to develop greener synthetic routes that minimize waste and reduce energy consumption. Such sustainable practices not only align with global environmental goals but also ensure cost-effectiveness in large-scale production.

Future research directions for this compound are multifaceted. Investigating its derivatives could lead to novel compounds with improved efficacy and reduced toxicity. Furthermore, exploring its potential in combination therapies may unlock new treatment paradigms for complex diseases. The integration of artificial intelligence into drug discovery processes promises to accelerate these efforts by predicting promising candidates based on vast datasets.

In conclusion, Carbamic acid,(4-methyl-1,3-phenylene)bis-, bis(1-methylethyl) ester (9CI), represented by CAS No. 42592-07-4, stands as a testament to the ingenuity of modern chemical research. Its unique structure and versatile reactivity make it a valuable asset in pharmaceutical development. As our understanding of biological systems continues to evolve, compounds like this one will play an increasingly pivotal role in shaping future therapies.

• 74965-31-4(N-(tert-Butoxycarbonyl)-2-methylaniline)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)